Apoptosis in leukemias: regulation and therapeutic targeting.
about
Evaluation of apoptosis induction by concomitant inhibition of MEK, mTOR, and Bcl-2 in human acute myelogenous leukemia cells.Low expression of PP2A regulatory subunit B55α is associated with T308 phosphorylation of AKT and shorter complete remission duration in acute myeloid leukemia patients.Phosphorylation of GSK3α/β correlates with activation of AKT and is prognostic for poor overall survival in acute myeloid leukemia patients.Analysis of the interplay between all-trans retinoic acid and histone deacetylase inhibitors in leukemic cells.Low probability activation of Bax/Bak can induce selective killing of cancer cells by generating heterogeneity in apoptosis.Synergistic suppression effect on tumor growth of acute myeloid leukemia by combining cytarabine with an engineered oncolytic vaccinia virus
P2860
Apoptosis in leukemias: regulation and therapeutic targeting.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Apoptosis in leukemias: regulation and therapeutic targeting.
@en
Apoptosis in leukemias: regulation and therapeutic targeting.
@nl
type
label
Apoptosis in leukemias: regulation and therapeutic targeting.
@en
Apoptosis in leukemias: regulation and therapeutic targeting.
@nl
prefLabel
Apoptosis in leukemias: regulation and therapeutic targeting.
@en
Apoptosis in leukemias: regulation and therapeutic targeting.
@nl
P2860
P1476
Apoptosis in leukemias: regulation and therapeutic targeting.
@en
P2093
Bing Carter
Ismael Samudio
P2860
P304
P356
10.1007/978-0-387-69259-3_12
P577
2010-01-01T00:00:00Z